ATE76306T1 - Pharmazeutische loesungen die dimethylsulfoxid enthalten. - Google Patents

Pharmazeutische loesungen die dimethylsulfoxid enthalten.

Info

Publication number
ATE76306T1
ATE76306T1 AT86301657T AT86301657T ATE76306T1 AT E76306 T1 ATE76306 T1 AT E76306T1 AT 86301657 T AT86301657 T AT 86301657T AT 86301657 T AT86301657 T AT 86301657T AT E76306 T1 ATE76306 T1 AT E76306T1
Authority
AT
Austria
Prior art keywords
solutions containing
pharmaceutical solutions
solution
skin
containing dimethylsulfoxide
Prior art date
Application number
AT86301657T
Other languages
English (en)
Inventor
Edmund Sandborn
Original Assignee
Dimethaid Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimethaid Research Inc filed Critical Dimethaid Research Inc
Application granted granted Critical
Publication of ATE76306T1 publication Critical patent/ATE76306T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT86301657T 1984-05-14 1986-03-07 Pharmazeutische loesungen die dimethylsulfoxid enthalten. ATE76306T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA000454281A CA1236029A (en) 1984-05-14 1984-05-14 Pharmaceutical solutions comprising dimethyl sulfoxide
EP19860301657 EP0235424B1 (de) 1984-05-14 1986-03-07 Pharmazeutische Lösungen die Dimethylsulfoxid enthalten

Publications (1)

Publication Number Publication Date
ATE76306T1 true ATE76306T1 (de) 1992-06-15

Family

ID=4127865

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86301657T ATE76306T1 (de) 1984-05-14 1986-03-07 Pharmazeutische loesungen die dimethylsulfoxid enthalten.

Country Status (5)

Country Link
US (2) US4575515A (de)
EP (1) EP0235424B1 (de)
AT (1) ATE76306T1 (de)
CA (1) CA1236029A (de)
DE (1) DE3685432D1 (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1236029A (en) * 1984-05-14 1988-05-03 Edmund Sandborn Pharmaceutical solutions comprising dimethyl sulfoxide
GB8517299D0 (en) * 1985-07-09 1985-08-14 Salim A S M Dermatologically active substances
IT1197056B (it) * 1986-08-01 1988-11-25 Intercos Italiana Pomata per mascherare difetti della pelle e cicatrici
DE3632359A1 (de) * 1986-09-24 1988-04-07 Troponwerke Gmbh & Co Kg Arzneimittelzubereitungen
DE3706421A1 (de) * 1987-02-27 1988-09-08 Robugen Gmbh Arzneimittel zur behandlung viraler erkrankungen
EP0348507A4 (en) * 1987-12-23 1990-12-27 Poltav Med Stomatolog Inst Pharmaceutical preparation for individual prophylaxis of venereal diseases and curing urogenital trichomoniasis
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
US5061724A (en) * 1989-07-18 1991-10-29 Sheldon Gertner Method for treating arthritically inflamed body joints, particularly joints having gouty arthritis
US5091379A (en) * 1989-08-31 1992-02-25 Du Pont Merck Pharmaceutical Company Topical antinflammatory compositions with minimal systemic absorption
US6113893A (en) * 1993-07-28 2000-09-05 Pfizer Inc. Psoriasis treatment
CA2168249C (en) * 1993-07-28 2001-02-27 Debbie L. Burnett Psoriasis treatment
US5665378A (en) * 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
WO1996028412A1 (en) * 1995-03-10 1996-09-19 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US6992107B1 (en) 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US6492420B2 (en) 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
GB9700396D0 (en) 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
US20040121023A1 (en) * 1998-11-02 2004-06-24 Victor Stevens Composition to alleviate pain and topical method of applying same
US6159977A (en) * 1998-11-16 2000-12-12 Astan, Inc. Therapeutic anti-fungal nail preparation
US20040048376A1 (en) * 2000-04-10 2004-03-11 Benoit Chabot Methods for modulating splicing and/or alternative splicing, and for identifying alternatively spliced units in genes
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
MXPA05001277A (es) 2002-08-02 2005-10-06 Ab Science 2-(3-aminoaril)amino-4-aril-tiazoles y su uso como inhibidores del c-kit.
US8450302B2 (en) * 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
US20040126343A1 (en) * 2002-12-26 2004-07-01 Garshowitz Solomon David Nail drug delivery
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
EP1684750B1 (de) * 2003-10-23 2010-04-28 AB Science 2-aminoaryloxazol-verbindungen als tyrosinkinase-hemmer
US20060223788A1 (en) * 2005-03-29 2006-10-05 Cathcart Clifton H Analgesic composition for topical use
CA2603826C (en) 2005-04-04 2013-03-12 Ab Science Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
US20060281822A1 (en) * 2005-04-20 2006-12-14 Cardinal Associates, Inc. Treatment and prevention of elevated homocysteine
US20100087546A1 (en) * 2005-04-20 2010-04-08 Biogenic Innovations, Llc Use of dimethyl sulfone (msm) to reduce homocysteine levels
US20080319092A1 (en) * 2005-08-05 2008-12-25 Nuvo Research Inc. Transdermal Drug Delivery Formulation
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
EP2324838A1 (de) 2005-09-12 2011-05-25 Abela Pharmaceuticals, Inc. Zusammensetzungen mit Dimethyl-Sulfoxid
WO2007033083A2 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same
US8480797B2 (en) * 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
ITLO20060004A1 (it) * 2006-08-08 2008-02-09 River Pharma Srl "lapille" e una nuova invenzione avente per oggetto una nuova combinazione chimica stabile per uso cosmetico e farmaceutico contenente come ingredienti attivi l'acido alfa-lipoico ed il dimetilsulfossido, in grado di migliorare l'assorbimento, la bio
RU2463038C2 (ru) 2006-10-17 2012-10-10 Нуво Рисерч Инк. Диклофенаковый гель
WO2008066627A2 (en) * 2006-10-24 2008-06-05 Board Of Regents, The University Of Texas System Adenosine signaling in diagnosis, treatment and prevention of priapism and erectile dysfunction
EP2211837B1 (de) 2007-06-08 2013-11-13 Troikaa Pharmaceuticals Ltd Nichtwässrige topische lösung aus diclofenac und verfahren zu ihrer herstellung
US20100100060A1 (en) * 2008-10-17 2010-04-22 Novartis Ag Applicator for pharmaceutical product and method of using same
BRPI0921494A2 (pt) * 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US20110092597A1 (en) * 2009-10-21 2011-04-21 Fangchen Lee Method for treating herpes virus infection
US9839609B2 (en) 2009-10-30 2017-12-12 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
CN102812022B (zh) 2010-01-12 2016-02-03 Ab科学有限公司 噻唑和噁唑激酶抑制剂
WO2011092273A1 (en) 2010-01-28 2011-08-04 Ab Science Treatment of gist with masitinib
WO2011112875A2 (en) 2010-03-10 2011-09-15 Nuvo Research Inc. Foamable formulation
WO2012154740A1 (en) 2011-05-11 2012-11-15 Pellexa Research, Llc Antifungal compositions for the treatment of skin and nails
PH12014500168A1 (en) 2011-07-27 2014-02-24 Ab Science Selective protein kinase inhibitors
US10813897B2 (en) * 2011-12-27 2020-10-27 Cmpd Licensing, Llc Composition and method for compounded therapy
WO2013122637A1 (en) 2012-02-17 2013-08-22 Capriotti Joseph Antifungal compositions for the treatment of skin and nails
US20140113970A1 (en) 2012-10-22 2014-04-24 Mallinckrodt LLC Covidien Dispensing system
JP2017508772A (ja) 2014-03-24 2017-03-30 エービー サイエンス 脾臓チロシンキナーゼ阻害剤としてのジアザスピロアルカノン置換型オキサゾール誘導体
EP3247365A4 (de) 2015-01-20 2018-08-01 Veloce BioPharma LLC Neuartige jodophorzusammensetzung und verfahren zur verwendung
ES2796276T3 (es) 2015-02-05 2020-11-26 Ab Science Compuestos con actividad antitumoral
EP3144307A1 (de) 2015-09-18 2017-03-22 AB Science Neue oxazol derivaten als syk kinasehemmer
WO2017172603A1 (en) 2016-03-28 2017-10-05 Tioga Research, Inc. Topical formulation
EP4034136A4 (de) * 2019-06-19 2023-07-05 The United States Government As Represented By The Department Of Veterans Affairs Formulierungen mit lithium zur behandlung von gichtarthropathie
EP4138806A4 (de) 2020-05-01 2024-04-24 Achelon, Inc. Schnell wirkende topische anästhetische formulierungen
US20250099369A1 (en) 2023-09-27 2025-03-27 Andros Pharmaceuticals Co., Ltd. Topical delivery compositions comprising non-steroidal anti-inflammatory drugs

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549770A (en) * 1963-12-09 1970-12-22 Crown Zellerbach Corp Therapeutic administration of effective amounts of dimethyl sulfoxide to human and animal subjects
CA1001075A (en) * 1963-12-09 1976-12-07 Stanley W. Jacob Pharmaceutical compositions containing dialkyl sulfoxides
BE644613A (de) * 1963-12-09 1964-07-01
US3740420A (en) * 1967-11-28 1973-06-19 Crown Zellerbach Corp Pharmaceutical compositions with dimethyl sulfoxide
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3711602A (en) * 1970-10-30 1973-01-16 Crown Zellerbach Corp Compositions for topical application for enhancing tissue penetration of physiologically active agents with dmso
US3743727A (en) * 1970-11-16 1973-07-03 Crown Zellerbach Corp Enhancing tissue penetration of certain antimicrobial agents with dimethyl sulfoxide
EP0051163A3 (de) * 1980-11-03 1983-02-16 Dr. Franz Köhler Chemie KG Intramuskulär schmerzlos anwendbare 4-Dimethylaminophenol Hydrochlorid-Lösung und Verfahren zu deren Herstellung
US4353896A (en) * 1981-06-08 1982-10-12 Levy Michael A Penetrating topical medicament
US4369190A (en) * 1981-06-23 1983-01-18 Schulte Thomas L Analgesic composition and use thereof to ameliorate intractable pain
GR81250B (en) * 1983-12-22 1985-11-19 American Home Prod Menthol enhancement of transdermal drug delivery
CA1236029A (en) * 1984-05-14 1988-05-03 Edmund Sandborn Pharmaceutical solutions comprising dimethyl sulfoxide

Also Published As

Publication number Publication date
EP0235424B1 (de) 1992-05-20
EP0235424A1 (de) 1987-09-09
US4652557A (en) 1987-03-24
CA1236029A (en) 1988-05-03
US4575515A (en) 1986-03-11
DE3685432D1 (de) 1992-06-25

Similar Documents

Publication Publication Date Title
ATE76306T1 (de) Pharmazeutische loesungen die dimethylsulfoxid enthalten.
EG18265A (en) New pharmaceutical preparation with extended release
PH24867A (en) A method of treating conditions associated with photodamaged skin by using pharmaceutical compositions containing p(22-(5,6,7,8 tetrahydro-5,5,8,8-tetramethyl-2-naphtyl)propenyl)phenylsulfone and derivatives thereof
DE3884081D1 (de) Anti-Akne-Zusammensetzung.
BR9406746A (pt) Composto processo para sua preparaçao preparado farmacêutico uso de um composto processo para a obtençao da inibiçao de trombina em um organismo humano ou animale fragmento estrutural
IS1564B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
DE10199027I1 (de) Fluorcytidinderivate deren Herstellung und Arzneimittel die diese Derivate enthalten
IT7823120A0 (it) Composti organici con proprieta' erbicide di acidi (pirimidilossi) fenossialcancarbossilici e loro derivati
BR9201207A (pt) Sulfonilaminocarbonitriazolinonas com substituintes ligados sobre oxigeno,processo para sua preparacao,agente herbicida,emprego,processos para o combate de ervas daninhas e para a preparacao de agentes e triazolinonas
DK0582239T3 (da) Farmaceutisk og/eller kosmetisk formulering
IS1565B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
IT1148277B (it) Derivati encefalinici dotati di attivita' analgesica e tranquillante neurolettica e procedimento per la loro preparazione
IT1256697B (it) Medicamenti per trattare condizioni infiammatorie o per analgesia.
DE68909958D1 (de) Phenoxyessigsäure-Derivate, ihre Herstellung, pharmazeutische Zusammensetzungen, die sie enthalten, und deren Verwendung.
KR910000158A (ko) 의약용 화합물 및 그것의 사용방법
DE69222318D1 (de) Hautpflegemittel
DK199789D0 (da) Anvendelse af et phenylquinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et topisk farmaceutisk praeparat til behandling af hud- og/eller slimepithelsygdomme
FR2598320B1 (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
BR9001484A (pt) Composicao inseticida e acaricida com efeito aperfeicoado,processo para aperfeicoar o efeito de uma substancia ativa inseticida
BG47648A3 (en) Method for preparing of triazolyl quanolinic compounds
NO891220L (no) Middel som inneholder salicylsyre for behandling av lepidose.
DE69332640D1 (de) Pharmazeutische pyridin-derivate
FI823817A7 (fi) Nitroimidatsoliyhdisteitä ja näppyjen hoidossa käyttökelpoisia seoksia.
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
DE58903565D1 (de) 1,2-naphthochinon-2-diazid-sulfonsaeureamide und lichtempfindliche gemische, die diese enthalten.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee